Angiodynamics (ANGO) Capital Expenditures (2010 - 2026)

Angiodynamics' Capital Expenditures history runs 17 years deep, the most recent figure standing at $413000.0 for Q2 2026.

• Quarterly Capital Expenditures fell 46.85% year-over-year to $413000.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $2.6 million (down 42.18% YoY) and the FY2026 annual result came in at $2.6 million, down 42.18% from the prior year.
• Capital Expenditures was $413000.0 for Q2 2026 at Angiodynamics, down from $1.0 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $2.8 million in Q1 2023 and bottomed at -$1.1 million in Q2 2023.
• A 5-year average of $862222.2 and a median of $772000.0 in 2023 frame the typical range for Capital Expenditures.
• Peak annual rise in Capital Expenditures reached 521.9% in 2023, while the deepest fall reached 206.83% in 2023.
• Angiodynamics' Capital Expenditures stood at -$137000.0 in 2022, then soared by 521.9% to $578000.0 in 2023, then soared by 101.38% to $1.2 million in 2024, then tumbled by 63.75% to $422000.0 in 2025, then fell by 2.13% to $413000.0 in 2026.
• Business Quant data shows ANGO's Capital Expenditures at $413000.0 in Q2 2026, $1.0 million in Q1 2026, and $422000.0 in Q4 2025.